Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001288065 | SCV001474900 | uncertain significance | not provided | 2019-11-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001288065 | SCV001492267 | uncertain significance | not provided | 2022-09-05 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 994543). This missense change has been observed in individual(s) with clinical features of HNF1A-related conditions (PMID: 12488961, 30155490). This variant is present in population databases (rs751368921, gnomAD 0.02%). This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 567 of the HNF1A protein (p.Val567Ile). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt HNF1A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects HNF1A function (PMID: 12488961). |
New York Genome Center | RCV002468213 | SCV002764517 | uncertain significance | Diabetes mellitus type 1; Type 1 diabetes mellitus 20; Maturity-onset diabetes of the young type 3; Type 2 diabetes mellitus | 2022-01-12 | criteria provided, single submitter | clinical testing |